PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics. “We are pleased that Cuong has agreed to … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has filed a premarket approval supplement with the FDA for its fourth generation rechargeable sacral neuromodulation implantable neurostimulator (INS). The fourth generation rechargeable INS reduces how frequently a patient … [Read more…]
BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies. Under the terms … [Read more…]
Company CEO and CBO will be available throughout BIO 2022 for partnering meetings RICHMOND, Calif.–(BUSINESS WIRE)–BioAge Labs, Inc. (“BioAge”, “the Company”), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that Kristen Fortney, PhD, CEO and Co-Founder of BioAge, will lead a panel discussion at … [Read more…]
TAIPEI, Taiwan–(BUSINESS WIRE)–On May 31st, 2022 Chunghwa Telecom Co., Ltd. (CHT) and Thonburi Hospital (TH) signed the “Smart Hospital” MOU. In light of the government of Thailand’s “Medical Hub of Asia” strategy in 2004, and its goal to become the leading Southeast Asian countries in providing international healthcare services, the two parties, CHT and TH, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Oral Rehydration Salt Market Research Report 2022 (Status and Outlook)” report has been added to ResearchAndMarkets.com’s offering. The Global Oral Rehydration Salt Market Size was estimated at USD 646.1 million in 2021 and is projected to reach USD 958.7 million by 2028, exhibiting a CAGR of 6.80% during the forecast period. The … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Mantle Cell Lymphoma Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028” report has been added to ResearchAndMarkets.com’s offering. According to a study published by Insure Insights, the global mantle cell lymphoma market is estimated to grow at a CAGR of 7.3% during the forecast period. Mantle cell lymphoma (MCL) … [Read more…]
− Moderna to become marketing authorization holder in Japan and be responsible for all import, local regulatory, development, quality assurance and commercial activities for Spikevax™ from 1st August 2022 − Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period. CAMBRIDGE, Mass. & … [Read more…]
OPEN Health is one of the leading global providers of scientific communications and market access services helping pharmaceutical companies to unlock the full potential of their clinical and commercial assets. Astorg will actively support and accelerate OPEN Health’s next phase of growth and innovation, drawing on their extensive experience of investing in the healthcare space. … [Read more…]
Antibody addresses high unmet medical need in large and rapidly growing kidney transplant market SCHLIEREN/ZURICH, Switzerland–(BUSINESS WIRE)–Memo Therapeutics AG (“MTx”), an innovator in the field of antibody discovery and development, announced today the initiation of a phase 1 clinical study targeting BK polyomavirus (“BKV”) infection in renal transplant patients. The phase 1, single-blind, partially randomized, … [Read more…]
